Skip to main content
. 2013 Jul 19;8(7):e68442. doi: 10.1371/journal.pone.0068442

Table 3. Cell proliferation assessed by CCK-8 assay after miR-196b and siRNA transfection.

n Inline graphic±s
miR-196b inhibitor 3 3.674±0.080*
miR-196b inhibitorcontrol 3 1.690±0.035
miR-196b mock 3 1.703±0.018
cells with over-expressedmiRNA-196b 3 1.716±0.079
K562 3 2.611±0.103
F 336.464 (welch)
P <0.001
BCR-ABL1 siRNA 3 1.821±0.063**
HOXA9 siRNA 3 1.939±0.079#
NC siRNA 3 2.717±0.126
mock siRNA 3 2.654±0.075
K562 3 2.675±0.129
cells with over-expressedmiRNA-196b 3 1.676±0.060
F 69.425 (welch)
P <0.001
*

vs. miR-196b inhibitor control, P = 0.001; * vs. miR-196b mock, P = 0.003; * vs. cells with over-expressed miRNA-196b, P<0.001; * vs. K562, P = 0.002; cells with over-expressed miRNA-196b vs. K562, P = 0.004 (missing case, pairwise comparisons). ** vs. HOXA9 siRNA, P = 0.851; ** vs. K562, P = 0.032; **vs. cells with over-expressed miRNA-196b, P = 0.495; # vs. K562, P = 0.034; # vs. cells with over-expressed miRNA-196b, P = 0.166 (missing case, pairwise comparisons).